Chelsea Plunges as RA Study Fails - May 31, 2012

Having trouble viewing this email? View in Browser.

Thursday, May 31, 2012  |   |   |   |  Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects. To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330. •  Chelsea Therapeutics, Inc. (CHTP) Plunges as RA Study Fails More... More Discontinuations News More Recalls and Warning News •  RXi Pharmaceuticals (RXII) Receives FDA Clearance to Begin Clinical Trial With RXI-109 More... More BLA/NDA/ANDA News More IND News More MAA News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp" ® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! Chicago, IL (USA) Boot Camp I Oct 23-24, 2012 Boot Camp II Oct 25, 2012 Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or http://www.safebridge.com. •  Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study More... •  Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in CRUISE-1 Phase III Clinical Study More... •  AEterna Zentaris (AEZS): Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos One More... •  A.P. Pharma, Inc. (APPA) Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control More... •  ImmunoCellular Therapeutics, Ltd to Present Long-term Survival Data from Clinical Study of ICT-107 in Glioblastoma Multiforme at American Society of Clinical Oncology Meeting More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Oregon Health & Science University (OHSU) Researchers Say Tart Cherries Have "the Highest Anti-Inflammatory Content of Any Food" More... •  Humans Can Sniff Out Old Age in Others, Monell Chemical Senses Center Study More... •  New Research Shows Runners Can Improve Health and Performance With Less Training, University of Copenhagen Study More... •  Exercise and a Healthy Diet of Fruits and Vegetables Extends Life Expectancy in Women in Their 70s, University of Michigan Study More... •  Ketamine Improved Bipolar Depression Within Minutes, National Institute of Mental Health Study More... More General Clinical Research News • Genetown (Billerica, Massachusetts) PAREXEL International Medical Director Clinical Trials Provide medical monitoring for assigned projects; function as medical representative on the project team; provide medical consultation as required or requested to client/sponsor or to other PAREXEL service groups; and assume the role of Senior Technical Lead in selected circumstances. • Biotech Beach (Carlsbad, California) Genoptix, Inc. Associate Director, Clinical Trial Support Oversee and provide day-to-day scientific expertise and guidance for clinical trial testing projects. Ensure all aspects of departmental activities meet established quality and technical standards, including CLIA and/or GCLP. • Pharm Country (Pittsburgh, Pennsylvania) ZOLL LifeVest Clinical Research Associate Assist with site selection and site qualification visits. Develop and review clinical materials including informed consent forms, case report forms, study manuals, Standard Operating Procedures, and other clinical materials to ensure compliance with regulatory, IRB, and company policies. • Biotech Bay (Fremont, California) Zosano Pharma, Inc. Associate Director, Clinical Operatioins Will provide operational and implementation expertise to the product/project teams under the guidance of the Chief Medical Officer. He or she will be the primary contact for the contract research organizations (CROs), laboratory vendors and clinical sites involved in the clinical trials. • BioForest (Seattle, Washington) Amgen Director, Preclinical Will provide strategic vision and portfolio leadership in support of small and large molecule drug development, registration, and/or post-marketing activities. He/she will be responsible for portfolio-level strategic and resource planning, communication, scientific/technical deliverables, and issue resolution. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! 2012 BIO Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Massachusetts region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • 2012 BIO Career Fair, Boston, MA June 18, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  La Jolla Pharmaceutical Company (LJPC) Announces Issuance of U.S. Patent Covering Modified Pectin Compositions More... •  Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform More... More Patent News •  Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown More... •  Pfizer Canada Inc. Release: New Personalized Medicine for ALK-positive Advanced or Metastatic Non-small Cell Lung Cancer More... •  Nouveau Life Pharmaceuticals (NOUV) Announces Release of Its Female Supplement More... More Drug Product News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. Hot Company Alder Biopharmaceuticals Inc. Corporate Headquarters 11804 North Creek Parkway South Bothell, Washington 98011 U.S.A. Phone: 425-205-2900 Fax: 425-205-2901 Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.